ModelEdge

Aveo Pharmaceuticals, Inc.
0001325879
Filing Type8-K
Filing Date1/18/2023
Updated1/19/23, 9:35 AM

Filing

8-K
Earnings Release

Exhibits

8-KEnd of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-3.1EX-3.1
EX-3.2EX-3.2
EX-99.1End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD